- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharmanutra SpA (PHNU)
Assess today's live Pharmanutra SpA (PHNU) share price, performance and insights using our live Milan: PHNU stock exchange data.
Analyse the historical data and Pharmanutra SpA share price performance charts on this page. Our technical summary section provides analysis on Pharmanutra share price buy/sell indicators using real-time data (or discuss the Pharmanutra (PHNU) stock price today with other investors in the Pharmanutra BIT share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BIT PHNU share price (ISIN: IT0005274094) to enhance your trading decisions with our free investment tools and resources.
What Is the Pharmanutra SpA Share Price Today?
The Pharmanutra share price today is 56.90.
What Is the Stock Symbol for Pharmanutra SpA
The stock symbol (or 'ticker') for Pharmanutra SpA is "PHNU."
What Stock Exchange Does Pharmanutra SpA Trade On?
Pharmanutra SpA is listed and trades on the Milan stock exchange.
Is Pharmanutra SpA a Good Stock to Buy?
Determining whether Pharmanutra SpA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Pharmanutra SpA share price performance charts on this page. Our technical summary section provides analysis on Pharmanutra share price buy/sell indicators using real-time data (or discuss the Pharmanutra (PHNU) stock price today with other investors in the Pharmanutra BIT share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current BIT PHNU share price (ISIN: IT0005274094) to enhance your trading decisions with our free investment tools and resources.
What Is the Pharmanutra SpA Share Price Today?
The Pharmanutra share price today is 56.90.
What Is the Stock Symbol for Pharmanutra SpA
The stock symbol (or 'ticker') for Pharmanutra SpA is "PHNU."
What Stock Exchange Does Pharmanutra SpA Trade On?
Pharmanutra SpA is listed and trades on the Milan stock exchange.
Is Pharmanutra SpA a Good Stock to Buy?
Determining whether Pharmanutra SpA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Milan
Currency in EUR
56.90
+0.20(+0.35%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.10
57.20
52 wk Range
38.75
60.00
PHNU is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.1057.20
52 wk Range
38.7560.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.76%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.76%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHNU Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
81.00
Upside
+42.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 5 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Pharmanutra Company Profile
Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and software for body bioimpedance analysis. The company sells its products through sales representatives, wholesalers, pharmacies, para-pharmacies, agents, distributors, online sales, local partners, and tenders. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.
Compare PHNU to Peers and Sector
Metrics to compare | PHNU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHNUPeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.2x | 20.2x | 12.1x | |
PEG Ratio | 3.97 | 0.02 | 0.03 | |
Price/Book | 8.2x | 2.3x | 1.5x | |
Price / LTM Sales | 4.3x | 1.2x | 0.9x | |
Upside (Analyst Target) | 48.1% | 10.6% | 21.2% | |
Fair Value Upside | Unlock | 13.0% | 11.8% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 81.00
(+42.36% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
0.50 / --
Revenue / Forecast
32.65M / --
People Also Watch
FAQ
What Is the Pharmanutra (PHNU) Share Price Today?
The live Pharmanutra share price today is 56.90
What Stock Exchange Does Pharmanutra (PHNU) Trade On?
Pharmanutra is listed and trades on the Milan Stock Exchange.
What Is the Ticker (Stock Symbol) for Pharmanutra?
The stock symbol (also called a 'ticker') for Pharmanutra is "PHNU."
Does Pharmanutra Pay Dividends? What’s The Current PHNU Dividend Yield?
Yes, PHNU Pays Dividends to its Shareholders. The current Pharmanutra dividend yield is 1.76%.
What Is the Current Pharmanutra Market Cap?
As of today, Pharmanutra market capitalisation is 548.35M.
What Is Pharmanutra's (PHNU) Earnings Per Share (TTM)?
The Pharmanutra EPS is currently 1.82 (Trailing Twelve Months).
When Is the Next Pharmanutra Earnings Date?
Pharmanutra's next earnings report will be released on 13 Mar 2026.
Is PHNU a Buy or Sell From a Technical Analyst Perspective?
Based on today's Pharmanutra moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pharmanutra Stock Split?
Pharmanutra has split 0 times. (See the PHNU stock split history page for full effective split date and price information.)
How Many Employees Does Pharmanutra Have?
Pharmanutra has 136 employees.
What is the current trading status of Pharmanutra (PHNU)?
As of 08 Jan 2026, Pharmanutra (PHNU) is trading at a price of 56.90, with a previous close of 56.70. The stock has fluctuated within a day range of 56.10 to 57.20, while its 52-week range spans from 38.75 to 60.00.
What Is Pharmanutra (PHNU) Price Target According to Analysts?
The average 12-month price target for Pharmanutra is EUR81, with a high estimate of EUR85 and a low estimate of EUR74. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +42.36% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.